Eu Ivdd Eu Ivd General No Longer On The Market 🇨🇳 China

Sharay aCL IgG (CLIA)

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06975070760922
Basic UDI-DI Code
B-06975070760922
Reference
18131001
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
No Longer On The Market

Additional Description

Sharay aCL IgG (CLIA) is intended for the in vitro quantitative measurement of aCL-IgG antibody in human serum and plasma as an aid in the diagnosis of primary Antiphospholipid Syndrome (APS) and those secondary to systemic lupus erythematosus (SLE) or SLE-like disorders in conjunction with other laboratory and clinical findings.

CND Nomenclature Codes

Code Description
W0102100501 ANTI-CARDIOLIPIN ANTIBODIES

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all